Zhejiang Jolly Pharmaceutical Co.,LTD 300181.SZ Stock
Zhejiang Jolly Pharmaceutical Co.,LTD Price Chart
Zhejiang Jolly Pharmaceutical Co.,LTD 300181.SZ Financial and Trading Overview
Zhejiang Jolly Pharmaceutical Co.,LTD stock price | 13.11 CNY |
Previous Close | 12.32 CNY |
Open | 12.47 CNY |
Bid | 12.18 CNY x 0 |
Ask | 12.19 CNY x 0 |
Day's Range | 12.18 - 12.63 CNY |
52 Week Range | 8.1 - 15.55 CNY |
Volume | 19.15M CNY |
Avg. Volume | 20.36M CNY |
Market Cap | 8.94B CNY |
Beta (5Y Monthly) | 0.292123 |
PE Ratio (TTM) | 26.586954 |
EPS (TTM) | 0.52 CNY |
Forward Dividend & Yield | 0.3 (2.45%) |
Ex-Dividend Date | May 30, 2023 |
1y Target Est | 15.12 CNY |
300181.SZ Valuation Measures
Enterprise Value | 7.77B CNY |
Trailing P/E | 26.586954 |
Forward P/E | 16.98611 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 4.8043494 |
Price/Book (mrq) | 3.1119592 |
Enterprise Value/Revenue | 4.177 |
Enterprise Value/EBITDA | 19.202 |
Trading Information
Zhejiang Jolly Pharmaceutical Co.,LTD Stock Price History
Beta (5Y Monthly) | 0.292123 |
52-Week Change | 41.60% |
S&P500 52-Week Change | 20.43% |
52 Week High | 15.55 CNY |
52 Week Low | 8.1 CNY |
50-Day Moving Average | 13.25 CNY |
200-Day Moving Average | 11.56 CNY |
300181.SZ Share Statistics
Avg. Volume (3 month) | 20.36M CNY |
Avg. Daily Volume (10-Days) | 18.89M CNY |
Shares Outstanding | 701.39M |
Float | 477.45M |
Short Ratio | N/A |
% Held by Insiders | 30.20% |
% Held by Institutions | 6.27% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.3 |
Trailing Annual Dividend Yield | 2.43% |
5 Year Average Dividend Yield | 109.00% |
Payout Ratio | 0.42029998 |
Last Split Factor | 17:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 16.20% |
Operating Margin (ttm) | 18.71% |
Gross Margin | 69.86% |
EBITDA Margin | 21.75% |
Management Effectiveness
Return on Assets (ttm) | 7.08% |
Return on Equity (ttm) | 13.41% |
Income Statement
Revenue (ttm) | 1.86B CNY |
Revenue Per Share (ttm) | 2.96 CNY |
Quarterly Revenue Growth (yoy) | 12.80% |
Gross Profit (ttm) | 1.27B CNY |
EBITDA | 404.9M CNY |
Net Income Avi to Common (ttm) | 301.71M CNY |
Diluted EPS (ttm) | 0.46 |
Quarterly Earnings Growth (yoy) | 41.79% |
Balance Sheet
Total Cash (mrq) | 1.04B CNY |
Total Cash Per Share (mrq) | 1.48 CNY |
Total Debt (mrq) | 166.16M CNY |
Total Debt/Equity (mrq) | 5.91 CNY |
Current Ratio (mrq) | 2.877 |
Book Value Per Share (mrq) | 3.93 |
Cash Flow Statement
Operating Cash Flow (ttm) | 244.87M CNY |
Levered Free Cash Flow (ttm) | -2022601 CNY |
Profile of Zhejiang Jolly Pharmaceutical Co.,LTD
Country | China |
State | N/A |
City | Huzhou |
Address | No. 388, Zhiyuan North Road |
ZIP | 313200 |
Phone | 86 57 2828 1088 |
Website | https://www.zuoli.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 2455 |
Zhejiang Jolly Pharmaceutical Co., Ltd. engages in the research, production, and marketing of Chinese medicinal products in China and internationally. The company offers Wuling capsule that is used to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kidney, or neurasthenia. It also provides Lingze tablet, which is used to treat frequent urination, dysuria, weak steam of urine, endless urine, and soreness and weakness of waist and knees caused by benign prostatic hyperplasia, kidney deficiency, and blood stasis; and Bailing tablet that is used as the adjuvant therapy to treat cough, asthma, back pain, and chronic bronchitis, which are caused by the deficiency of lungs and kidney. In addition, the company offers Linglianhua particles for the treatment of symptoms, including sweating, insomnia, dysphoria, heart palpitations, dreaminess, giddy tinnitus, lassitude in loin and legs, dry stool, and abnormal furred tongue, as well as weak pulse caused by perimenopausal syndrome, or disharmony of heart and kidney. Further, it provides azithromycin, clindamycin phosphate, doxapram, pefloxacin mesylate, adenosine cyclophosphate, and sodium nitroprusside injections. Additionally, the company offers materials, such as cordyceps cephalosporium, fermented cordyceps, and Wuling powders. It also invests and participates in the medical services of Deqing No.3 People's Hospital. The company was formerly known as Zhejiang Jolly Pharmaceutical Health Products Co., LTD. and changed its name to Zhejiang Jolly Pharmaceutical Co., Ltd. in 1998. Zhejiang Jolly Pharmaceutical Co., Ltd. was founded in 2000 and is based in Huzhou, China.
Q&A For Zhejiang Jolly Pharmaceutical Co.,LTD Stock
What is a current 300181.SZ stock price?
Zhejiang Jolly Pharmaceutical Co.,LTD 300181.SZ stock price today per share is 13.11 CNY.
How to purchase Zhejiang Jolly Pharmaceutical Co.,LTD stock?
You can buy 300181.SZ shares on the Shenzhen exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zhejiang Jolly Pharmaceutical Co.,LTD?
The stock symbol or ticker of Zhejiang Jolly Pharmaceutical Co.,LTD is 300181.SZ.
Which industry does the Zhejiang Jolly Pharmaceutical Co.,LTD company belong to?
The Zhejiang Jolly Pharmaceutical Co.,LTD industry is Biotechnology.
How many shares does Zhejiang Jolly Pharmaceutical Co.,LTD have in circulation?
The max supply of Zhejiang Jolly Pharmaceutical Co.,LTD shares is 701.39M.
What is Zhejiang Jolly Pharmaceutical Co.,LTD Price to Earnings Ratio (PE Ratio)?
Zhejiang Jolly Pharmaceutical Co.,LTD PE Ratio is 25.21153800 now.
What was Zhejiang Jolly Pharmaceutical Co.,LTD earnings per share over the trailing 12 months (TTM)?
Zhejiang Jolly Pharmaceutical Co.,LTD EPS is 0.52 CNY over the trailing 12 months.
Which sector does the Zhejiang Jolly Pharmaceutical Co.,LTD company belong to?
The Zhejiang Jolly Pharmaceutical Co.,LTD sector is Healthcare.